Antibodies against secreted fri zzled related protein-4 (SFRP-4 )

Details for Australian Patent Application No. 2007213655 (hide)

Owner Novartis AG

Inventors Hillenbrand, Rainer; Zaar, Annette; Vitaliti, Alessandra

Agent Davies Collison Cave

Pub. Number AU-A-2007213655

PCT Pub. Number WO2007/090872

Priority 60/771,651 09.02.06 US

Filing date 8 February 2007

Wipo publication date 16 August 2007

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

7 August 2008 PCT application entered the National Phase

  PCT publication WO2007/090872 Priority application(s): WO2007/090872

6 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007213656-Oxidoreductases and processes utilising such enzymes

2007213649-Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same